PD‐L1 TPS of ≥50% was first shown to display a higher ORR in the KEYNOTE‐001 and KEYNOTE‐010 studies compared to those with 50% or lower PD‐L1 TPS in NSCLC. This evidence concerns the gene CD274 and non-small cell lung carcinoma.